Connecticut Mental Health Center and the Child Study Center.
Expert Rev Neurother. 2013 Aug;13(8):887-94. doi: 10.1586/14737175.2013.814938. Epub 2013 Aug 16.
This meta-analysis investigates the efficacy of pharmacological treatments for pathological gambling (PG).
We searched for randomized, placebo-controlled trials examining pharmacotherapy of pathological gamblers. A fixed-effects model was used to calculate the standardized mean difference (SMD) of the benefit of medication (stratified by class) compared to placebo. Secondary analyses examined the effects of publication bias, year of publication and adherence to intention-to-treat (ITT) principles on reported efficacy of interventions.
Meta-analysis included 14 trials involving 1024 participants. Opiate antagonists demonstrated a small but significant benefit compared to placebo (SMD = 0.22 ± 0.10 (95% CI: 0.03-0.41), z = 2.3, p = 0.02). The reported efficacy of opiate antagonists was significantly associated with non-adherence to ITT principles in trials and earlier year of publication. Other medications had non-significant effect sizes compared to placebo but similar in magnitude to opiate antagonists.
Current trial data provides limited support for the use of any pharmacological agent in the treatment of pathological gambling.
本荟萃分析调查了药物治疗病理性赌博(PG)的疗效。
我们检索了评估病理性赌徒药物治疗的随机、安慰剂对照试验。采用固定效应模型计算药物治疗(按类别分层)与安慰剂相比的效益的标准化均数差(SMD)。次要分析检查了发表偏倚、发表年份和对意向治疗(ITT)原则的遵守情况对干预措施报告疗效的影响。
荟萃分析纳入了涉及 1024 名参与者的 14 项试验。阿片类拮抗剂与安慰剂相比显示出较小但有统计学意义的益处(SMD = 0.22 ± 0.10(95% CI:0.03-0.41),z = 2.3,p = 0.02)。阿片类拮抗剂的报告疗效与试验中不遵守 ITT 原则以及发表年份较早显著相关。与安慰剂相比,其他药物的效应大小无统计学意义,但与阿片类拮抗剂相似。
目前的试验数据对使用任何药物治疗病理性赌博提供了有限的支持。